Top

Forensic Toxicology

Published in:

01-07-2019 | Cannabinoid | Original Article

Cytotoxicity of the synthetic cannabinoids 5C-AKB48, 5F-MDMB-PINACA, ADB-CHMINACA, MDMB-CHMICA and NM-2201 in A549 and TR146 cell lines

Authors: Katharina Elisabeth Grafinger, Harpreet Kaur Mandhair, Alain Broillet, Jürg Gertsch, Wolfgang Weinmann

Published in: Forensic Toxicology | Issue 2/2019

Abstract

Purpose

The aim of the present study was to evaluate the cytotoxicity of five synthetic cannabinoids in two cell lines, for which both reference standards and herbal blends were available.

Methods

An in-house smoking device was developed to produce smoke condensates. The cell viability of reference standards, herbal blend extracts and smoke condensates was measured using an MTT assay in the A549 lung carcinoma cell line and the TR146 buccal carcinoma cell line. Damiana extracts and damiana smoke condensates were also tested for cytotoxicity.

Results

For the reference standards of 5F-MDMB-PINACA, ADB-CHMINACA and MDMB-CHMICA, a significant concentration-dependent decrease in cell viability was observed. ADB-CHMINACA and MDMB-CHMICA extracts were more potent than the damiana extract, whereas the NM-2201 blend extract abrogated the effects of the damiana leaves. Compared with damiana smoke condensate, MDMB-CHMICA smoke condensate had higher sensitivity, while ADB-CHMINACA smoke condensate was less potent.

Conclusions

This is the first study to investigate the comparative cytotoxicity of reference standards, herbal blend extracts and smoke condensates of synthetic cannabinoids. The data showed that the presence of damiana plant contributed to enhancing the cytotoxicity of 5C-AKB48, 5F-MDMB-PINACA, and MDMB-CHMICA. The plant effects were generally more marked for smoke condensates. MDMB-CHMICA was the most potent substance. The NM-2201 reference standard and extract led to an increase in cell viability as compared to the control. This is of special interest, because the NM-2201 herbal blend extract seemed to abrogate the effects of the damiana leaf extracts. Further studies would be necessary to assess potential procarcinogenic or tumorigenic effects of NM-2201.

Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832–837. https://doi.org/10.1002/jms.1558 CrossRefPubMed

Evans-Brown M, Sedefov R (2017) New psychoactive substances: driving greater complexity into the drug problem. Addiction 112:36–38. https://doi.org/10.1111/add.13528 CrossRefPubMed

EMCDDA (2018) European Drug Report 2018: trends and developments. Publications Office of the European Union, Luxembourg. https://doi.org/10.2810/800331 CrossRef

Seely KA, Lapoint J, Moran JH, Fattore L (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 39:234–243. https://doi.org/10.1016/j.pnpbp.2012.04.017 CrossRefPubMedPubMedCentral

EMCDDA (2015) European Drug Report 2015: trends and developments. Publications Office of the European Union, Luxembourg. https://doi.org/10.2810/084165 CrossRef

Schäffer MG, Pütz T, Zimmermann M (2013) Assessment of the presence of damiana in herbal blends of forensic interest based on comprehensive two-dimensional gas chromatography. Forensic Toxicol 31:251–262. https://doi.org/10.1007/s11419-013-0186-5 CrossRef

Noble C, Cannaert A, Linnet K, Stove CP (2019) Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors. Drug Test Anal 11:501–511. https://doi.org/10.1002/dta.2517 CrossRefPubMed

Pertwee RG (2008) The diverse CB₁ and CB₂ receptor pharmacology of three plant cannabinoids: Δ⁹-tetrahydrocannabinol, cannabidiol and Δ⁹-tetrahydrocannabivarin. Br J Pharmacol 153:199–215. https://doi.org/10.1038/sj.bjp.0707442 CrossRef

Pertwee RG (1997) Pharmacology of cannabinoid CB₁ and CB₂ receptors. Pharmacol Ther 74:129–180. https://doi.org/10.1016/S0163-7258(97)82001-3 CrossRef

10.

Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563–583. https://doi.org/10.1523/JNEUROSCI.11-02-00563.1991 CrossRefPubMed

11.

Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65. https://doi.org/10.1038/365061a0 CrossRefPubMed

12.

Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol 54:1–13. https://doi.org/10.3109/15563650.2015.1110590 CrossRef

13.

Winstock AR, Barratt MJ (2013) The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Hum Psychopharmacol 28:390–393. https://doi.org/10.1002/hup.2292 CrossRefPubMed

14.

Hill SL, Najafi J, Dunn M, Acheampong P, Kamour A, Grundlingh J, Blain PG, Thomas SH (2016) Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study. Clin Toxicol 54:638–643. https://doi.org/10.1080/15563650.2016.1190980 CrossRef

15.

Schoeder CT, Hess C, Madea B, Meiler J, Müller CE (2018) Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds. Forensic Toxicol 36:385–403. https://doi.org/10.1007/s11419-018-0415-z CrossRefPubMedPubMedCentral

16.

Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE (2016) Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol 34:329–343. https://doi.org/10.1007/s11419-016-0320-2 CrossRefPubMedPubMedCentral

17.

Mardal M, Dalsgaard PW, Qi B, Mollerup CB, Annaert P, Linnet K (2018) Metabolism of the synthetic cannabinoids AMB-CHMICA and 5C-AKB48 in pooled human hepatocytes and rat hepatocytes analyzed by UHPLC-(IMS)-HR-MS^E. J Chromatogr B 1083:189–197. https://doi.org/10.1016/j.jchromb.2018.03.016 CrossRef

18.

Couceiro J, Bandarra S, Sultan H, Bell S, Constantino S, Quintas A (2016) Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines. Forensic Sci Int 264:100–105. https://doi.org/10.1016/j.forsciint.2016.03.024 CrossRefPubMed

19.

Koller VJ, Zlabinger GJ, Auwärter V, Fuchs S, Knasmueller S (2013) Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB₁. Arch Toxicol 87:1287–1297. https://doi.org/10.1007/s00204-013-1029-1 CrossRefPubMed

20.

Wojcieszak J, Krzemień W, Zawilska JB (2016) JWH-133, a selective cannabinoid CB₂ receptor agonist, exerts toxic effects on neuroblastoma SH-SY5Y cells. J Mol Neurosci 58:441–445. https://doi.org/10.1007/s12031-016-0726-7 CrossRefPubMed

21.

Wojcieszak J, Andrzejczak D, Woldan-Tambor A, Zawilska JB (2016) Cytotoxic activity of pyrovalerone derivatives, an emerging group of psychostimulant designer cathinones. Neurotox Res 30:239–250. https://doi.org/10.1007/s12640-016-9640-6 CrossRefPubMed

22.

Kevin RC, Kovach AL, Lefever TW, Gamage TF, Wiley JL, McGregor IS, Thomas BF (2019) Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures. Forensic Toxicol 37:17–26. https://doi.org/10.1007/s11419-018-0430-0 CrossRefPubMed

23.

Hädener M, Gelmi TJ, Martin-Fabritius M, Weinmann W, Pfäffli M (2019) Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute". Int J Legal Med 133:821–832. https://doi.org/10.1007/s00414-018-01994-y CrossRefPubMed

24.

Marx V (2014) Cell-line authentication demystified. Nat Methods 11:483–488. https://doi.org/10.1038/nmeth.2932 CrossRefPubMed

25.

Tomiyama K, Funada M (2011) Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108–15 cell line. Toxicol Lett 207:12–17. https://doi.org/10.1016/j.toxlet.2011.08.021 CrossRefPubMed

26.

Tomiyama K, Funada M (2014) Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB₁ receptors and apoptotic cell death. Toxicol Appl Pharmacol 274:17–23. https://doi.org/10.1016/j.taap.2013.10.028 CrossRefPubMed

27.

EMCDDA (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB). Publications Office of the European Union, Luxembourg, p 16. https://doi.org/10.2810/210307

28.

Adamowicz P (2016) Fatal intoxication with synthetic cannabinoid MDMB-CHMICA. Forensic Sci Int 261:e5–e10. https://doi.org/10.1016/j.forsciint.2016.02.024 CrossRefPubMed

29.

Adamowicz P, Gieron J (2016) Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA. Clin Toxicol 54:650–654. https://doi.org/10.1080/15563650.2016.1190016 CrossRef

30.

Angerer V, Franz F, Schwarze B, Moosmann B, Auwärter V (2016) Reply to ‘sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA'. J Anal Toxicol 40:240–242. https://doi.org/10.1093/jat/bkw004 CrossRefPubMedPubMedCentral

Title: Cytotoxicity of the synthetic cannabinoids 5C-AKB48, 5F-MDMB-PINACA, ADB-CHMINACA, MDMB-CHMICA and NM-2201 in A549 and TR146 cell lines
Authors: Katharina Elisabeth Grafinger
Harpreet Kaur Mandhair
Alain Broillet
Jürg Gertsch
Wolfgang Weinmann
Publication date: 01-07-2019
Publisher: Springer Singapore
Keywords: Cannabinoid
Smoking and Nicotine Detoxification
Published in: Forensic Toxicology / Issue 2/2019
Print ISSN: 1860-8965
Electronic ISSN: 1860-8973
DOI: https://doi.org/10.1007/s11419-019-00474-1

At a glance: The STEP trials

Springer Medicine

Cytotoxicity of the synthetic cannabinoids 5C-AKB48, 5F-MDMB-PINACA, ADB-CHMINACA, MDMB-CHMICA and NM-2201 in A549 and TR146 cell lines

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

Hyperreflexia induced by XLR-11 smoke is caused by the pyrolytic degradant

Suicidal deaths due to helium inhalation

Comments on the paper entitled “Rapid tentative identification of synthetic cathinones in seized products taking advantage of the full capabilities of triple quadrupole analyzer”

Comparison of measurement methods for carboxyhemoglobin in blood samples based on visible spectra with 17 institutions

Quantification of clitidine in caps and stems of poisonous mushroom Paralepistopsis acromelalga by hydrophilic interaction liquid chromatography–tandem mass spectrometry